SCHEMBL10094185

SCHEMBL10094185

CC(C)c1ccccc1Nc1cccc(N)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XIAP P98170 1/20 0.45
▸ BIRC2 Q13490 1/20 0.45
▸ CCR4 P51679 1/20 0.43
▸ EGFR P00533 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ SCN9A Q15858 1/20 0.39
▸ SIGMAR1 Q99720 2/20 0.38
▸ GRIN2D O15399 1/20 0.38
▸ GRIN3B O60391 1/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2A Q12879 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ GRIN2C Q14957 1/20 0.38
▸ GRIN3A Q8TCU5 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ NOS3 P29474 1/20 0.36
▸ NOS2 P35228 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094605 0.78 HTT (0.49) XIAPBIRC2L3MBTL1SCN9ANOS3
SCHEMBL10094190 0.77 GRM5 (0.46) XIAPBIRC2PIK3CAPIK3CBPIK3CG
SCHEMBL10094215 0.77 CCR4 (0.44) CCR4EGFRL3MBTL1PIK3CAPIK3CB
SCHEMBL10094171 0.76 L3MBTL1 (0.62) CCR4EGFRL3MBTL1PIK3CAPIK3CB
SCHEMBL10094163 0.75 MEN1 (0.66) CCR4L3MBTL1PIK3CAPIK3CBPIK3CG
SCHEMBL3958491 0.74 L3MBTL1 (0.57) CCR4EGFRL3MBTL1PIK3CAPIK3CB
SCHEMBL9878020 0.74 SCN9A (0.53) XIAPBIRC2PIK3CAPIK3CGSCN9A
SCHEMBL10094195 0.72 GOT1 (0.43) CCR4EGFRL3MBTL1PIK3CAPIK3CB
SCHEMBL2457495 0.72 MAPT (0.50) CCR4EGFRL3MBTL1PIK3CAPIK3CB
SCHEMBL9764653 0.70 L3MBTL1 (0.57) CCR4L3MBTL1SIGMAR1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 XIAP 727/4885BIRC2 388/4885CCR4 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback